Variant report
Variant | nsv521366 |
---|---|
Chromosome Location | chr1:86916767-86922161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:86910474..86912190-chr1:86919287..86922242,2 | K562 | blood: | |
2 | chr1:86916080..86919550-chr1:86920732..86922559,3 | K562 | blood: | |
3 | chr1:86921099..86922741-chr1:86931533..86933819,2 | MCF-7 | breast: | |
4 | chr1:86916080..86919550-chr1:86920732..86922559,3 | K562 | blood: | |
5 | chr1:86921660..86923666-chr1:86931095..86932797,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs969786 | chr1:86916767-86916768 | Enhancers Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs146993079 | chr1:86916769-86916770 | Enhancers Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544216874 | chr1:86916804-86916805 | Enhancers Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs969787 | chr1:86916821-86916822 | Enhancers Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs1334138 | chr1:86916824-86916825 | Enhancers Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546040755 | chr1:86916852-86916853 | Enhancers Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs969788 | chr1:86916856-86916857 | Enhancers Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs185053996 | chr1:86916940-86916941 | Enhancers Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs969789 | chr1:86916948-86916949 | Enhancers Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs533725787 | chr1:86916969-86916970 | Enhancers Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547232848 | chr1:86917016-86917017 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs969790 | chr1:86917017-86917018 | Enhancers Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs56098312 | chr1:86917033-86917034 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76560428 | chr1:86917038-86917039 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376126796 | chr1:86917053-86917054 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191032640 | chr1:86917085-86917086 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535131934 | chr1:86917119-86917120 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386633159 | chr1:86917137-86917138 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4291478 | chr1:86917139-86917140 | Enhancers Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs540826410 | chr1:86917143-86917144 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138912550 | chr1:86917211-86917212 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71650262 | chr1:86917212-86917213 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560619036 | chr1:86917264-86917265 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113111568 | chr1:86917292-86917293 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138106781 | chr1:86917311-86917312 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555286055 | chr1:86917332-86917333 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34620827 | chr1:86917344-86917345 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570385465 | chr1:86917376-86917377 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531712736 | chr1:86917394-86917395 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140802254 | chr1:86917400-86917401 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561642119 | chr1:86917449-86917450 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2791521 | chr1:86917500-86917501 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs6576834 | chr1:86917562-86917563 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs570271950 | chr1:86917634-86917635 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539274038 | chr1:86917640-86917641 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535638322 | chr1:86917704-86917705 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183349774 | chr1:86917802-86917803 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150102787 | chr1:86917851-86917852 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374651123 | chr1:86917884-86917885 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368712006 | chr1:86917885-86917886 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4656100 | chr1:86917944-86917945 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs555115340 | chr1:86917955-86917956 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4656101 | chr1:86917957-86917958 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4656102 | chr1:86917960-86917961 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572073474 | chr1:86917985-86917986 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537903610 | chr1:86917997-86917998 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534451662 | chr1:86918001-86918002 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554518179 | chr1:86918005-86918006 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149235332 | chr1:86918007-86918008 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77654286 | chr1:86918042-86918043 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 16397240 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:86897200-86922600 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:86897200-86922800 | Strong transcription | HMEC | breast |
3 | chr1:86903400-86926800 | Weak transcription | Esophagus | oesophagus |
4 | chr1:86914400-86917000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr1:86914600-86930800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr1:86915200-86920000 | Strong transcription | NHEK | skin |
7 | chr1:86915400-86917400 | Enhancers | HUVEC | blood vessel |
8 | chr1:86915600-86919400 | Weak transcription | K562 | blood |
9 | chr1:86916400-86917000 | Enhancers | Dnd41 | blood |
10 | chr1:86916400-86917400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr1:86916400-86921600 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr1:86916800-86917200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr1:86916800-86917400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr1:86917000-86930600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr1:86919200-86919600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr1:86919400-86919600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr1:86919400-86919800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr1:86919400-86919800 | Enhancers | K562 | blood |
19 | chr1:86919800-86920800 | Weak transcription | K562 | blood |
20 | chr1:86920000-86924000 | Weak transcription | NHEK | skin |
21 | chr1:86920800-86923400 | Enhancers | K562 | blood |
22 | chr1:86921600-86925400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |